Nutrient Combinations Sensed by L-Cell Receptors Potentiate GLP-1 Secretion

Nalini Sodum,Orvokki Mattila,Ravikant Sharma,Remi Kamakura,Vesa-Pekka Lehto,Jaroslaw Walkowiak,Karl-Heinz Herzig,Ghulam Shere Raza

DOI: https://doi.org/10.3390/ijms25021087

IF: 5.6

2024-01-16

International Journal of Molecular Sciences

Abstract:Obesity is a risk factor for cardiometabolic diseases. Nutrients stimulate GLP-1 release; however, GLP-1 has a short half-life (<2 min), and only <10–15% reaches the systemic circulation. Human L-cells are localized in the distal ileum and colon, while most nutrients are absorbed in the proximal intestine. We hypothesized that combinations of amino acids and fatty acids potentiate GLP-1 release via different L-cell receptors. GLP-1 secretion was studied in the mouse enteroendocrine STC-1 cells. Cells were pre-incubated with buffer for 1 h and treated with nutrients: alpha-linolenic acid (αLA), phenylalanine (Phe), tryptophan (Trp), and their combinations αLA+Phe and αLA+Trp with dipeptidyl peptidase-4 (DPP4) inhibitor. After 1 h GLP-1 in supernatants was measured and cell lysates taken for qPCR. αLA (12.5 μM) significantly stimulated GLP-1 secretion compared with the control. Phe (6.25–25 mM) and Trp (2.5–10 mM) showed a clear dose response for GLP-1 secretion. The combination of αLA (6.25 μM) and either Phe (12.5 mM) or Trp (5 mM) significantly increased GLP-1 secretion compared with αLA, Phe, or Trp individually. The combination of αLA and Trp upregulated GPR120 expression and potentiated GLP-1 secretion. These nutrient combinations could be used in sustained-delivery formulations to the colon to prolong GLP-1 release for diminishing appetite and preventing obesity.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

This paper mainly discusses how to enhance the secretion of GLP-1 (glucagon-like peptide-1) by specific combinations of nutrients, in order to control appetite and prevent obesity. GLP-1 is a hormone secreted by intestinal L cells after food intake, which can suppress appetite, delay gastric emptying, and promote insulin secretion. However, the active form of GLP-1 in the body has a short half-life and a low proportion entering the circulation. In the study, scientists used the mouse intestinal endocrine cell line STC-1 to investigate the effects of different combinations of amino acids (phenylalanine Phe and tryptophan Trp) with unsaturated fatty acid (alpha-linolenic acid alphaLA) on GLP-1 secretion. The results showed that alphaLA, Phe, and Trp all stimulated GLP-1 secretion in a dose-dependent manner. Specifically, the combination of alphaLA with Trp or Phe significantly increased GLP-1 secretion compared to individual nutrients. Moreover, these combinations also upregulated the expression of the GPR120 gene in cells, which may be related to the increase in GLP-1 secretion. The conclusion of the paper suggests that the combination of these nutrients may help develop formulations that release continuously to the colon, thereby prolonging the action of GLP-1, reducing appetite, and preventing obesity. These findings provide a new perspective for further research on GLP-1 as a potential strategy for the treatment of obesity.

Nutrient Combinations Sensed by L-Cell Receptors Potentiate GLP-1 Secretion

Selective stimulation of colonic L cells improves metabolic outcomes in mice

Behavioural and neurochemical mechanisms underpinning the feeding-suppressive effect of GLP-1/CCK combinatorial therapy

Co-storage and release of insulin-like peptide-5, glucagon-like peptide-1 and peptideYY from murine and human colonic enteroendocrine cells

Combined Amylin/GLP-1 pharmacotherapy to promote and sustain long-lasting weight loss

Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes

Decoy bypass for appetite suppression in obese adults: role of synergistic nutrient sensing receptors GPR84 and FFAR4 on colonic endocrine cells

Molecular basis of enhanced GLP-1 signaling mediated by GLP-1(9-36) in conjunction with LSN3318839

Effects of a long-acting secretin peptide analog alone and in combination with a GLP-1R agonist in a diet-induced obesity mouse model

Positive interplay between FFAR4/GPR120, DPP-IV inhibition and GLP-1 in beta cell proliferation and glucose homeostasis in obese high fat fed mice

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice

L-Cell Expression of Melanocortin-4-Receptor Is Marginal in Most of the Small Intestine in Mice and Humans and Direct Stimulation of Small Intestinal Melanocortin-4-Receptors in Mice and Rats Does Not Affect GLP-1 Secretion

Short-Chain Fatty Acids Stimulate Glucagon-Like Peptide-1 Secretion via the G-Protein–Coupled Receptor FFAR2

GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions

Mechanism of fructo-oligosaccharides on potentiating GLP-1 release from enteroendocrine cells

Mechanistic insights into the detection of free fatty and bile acids by ileal glucagon-like peptide-1 secreting cells

Long Term Exposure to a Grape Seed Proanthocyanidin Extract Enhances L-Cell Differentiation in Intestinal Organoids

Control of insulin secretion by GLP-1

Nutrient-Induced Cellular Mechanisms of Gut Hormone Secretion

Multiple Factors Related to the Secretion of Glucagon-Like Peptide-1

Insulin Sensitizers Improve the Glp-1 Secretion and the Amount of Intestinal L Cells on High-Fat-Diet-Induced Catch-Up Growth